Michael Hoelscher

Overview

Best Publications

• Virological assessment of hospitalized patients with COVID-2019.

  Roman Wölfel;Victor M. Corman;Wolfgang Guggemos;Michael Seilmaier

  7428
  Citations

• Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.

  Camilla Rothe;Mirjam Schunk;Peter Sothmann;Gisela Bretzel

  4985
  Citations

• Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test

  Stephen D Lawn;Peter Mwaba;Peter Mwaba;Matthew Bates;Amy Piatek

  632
  Citations

• Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial

  Grant Theron;Lynn Zijenah;Duncan Chanda;Petra Clowes;Petra Clowes

  562
  Citations

• Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages.

  David Stucki;David Stucki;Daniela Brites;Daniela Brites;Leïla Jeljeli;Mireia Coscolla;Mireia Coscolla

  471
  Citations

• Operational Feasibility of Using Loop-Mediated Isothermal Amplification for Diagnosis of Pulmonary Tuberculosis in Microscopy Centers of Developing Countries

  Catharina C. Boehme;Pamela Nabeta;German Henostroza;Rubhana Raqib

  454
  Citations

• New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects

  Alimuddin I Zumla;Alimuddin I Zumla;Stephen H Gillespie;Michael Hoelscher;Patrick P J Philips

  426
  Citations

• High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

  Martin J Boeree;Norbert Heinrich;Rob Aarnoutse;Andreas H Diacon

  419
  Citations

• Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting

  Grant Theron;Jonny Peter;Richard van Zyl-Smit;Hridesh Mishra

  416
  Citations

• Host-directed therapies for infectious diseases: current status, recent progress, and future prospects

  Alimuddin Zumla;Alimuddin Zumla;Martin Rao;Martin Rao;Robert S Wallis;Stefan H E Kaufmann

  393
  Citations

• Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts

  Ben J Marais;Knut Lönnroth;Stephen D Lawn;Stephen D Lawn;Giovanni Battistai Migliori

  373
  Citations

• Drug-resistant tuberculosis: time for visionary political leadership

  Ibrahim Abubakar;Ibrahim Abubakar;Matteo Zignol;Dennis Falzon;Mario Raviglione

  364
  Citations

• A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis

  M.J. Boeree;A.H. Diacon;R. Dawson;K. Narunsky

  360
  Citations

• Clinical presentation and virological assessment of hospitalized cases of coronavirus disease 2019 in a travel-associated transmission cluster

  Woelfel R;Corman Vm;Guggemos W;Seilmaier M

  357
  Citations

• Single-Dose Azithromycin versus Penicillin G Benzathine for the Treatment of Early Syphilis

  Gabriele Riedner;Mary Rusizoka;Jim Todd;Leonard Maboko

  340
  Citations

• Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial

  Jonny G Peter;Lynn S Zijenah;Duncan Chanda;Duncan Chanda;Petra Clowes;Petra Clowes

  312
  Citations

• Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers

  Robert S Wallis;Markus Maeurer;Peter Mwaba;Jeremiah Chakaya

  304
  Citations

• Preferential infection and depletion of Mycobacterium tuberculosis–specific CD4 T cells after HIV-1 infection

  Christof Geldmacher;Njabulo Ngwenyama;Alexandra Schuetz;Constantinos Petrovas

  292
  Citations

• Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities

  Ruth McNerney;Markus Maeurer;Ibrahim Abubakar;Ibrahim Abubakar;Ben Marais

  266
  Citations

• Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies

  Alimuddin Zumla;Jeremiah Chakaya;Rosella Centis;Lia D'Ambrosio

  265
  Citations

• Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study

  Josephine M Bryant;Simon R Harris;Julian Parkhill;Rodney Dawson

  242
  Citations

• Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis

  C. Boehme;E. Molokova;F. Minja;S. Geis

  231
  Citations

• CD8 T-Cell Recognition of Multiple Epitopes within Specific Gag Regions Is Associated with Maintenance of a Low Steady-State Viremia in Human Immunodeficiency Virus Type 1-Seropositive Patients

  Christof Geldmacher;Jeffrey R. Currier;Eva Herrmann;Antelmo Haule

  230
  Citations

• Rapid and Accurate Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert MTB/RIF Assay-A Clinical Validation Study

  Andrea Rachow;Alimuddin Zumla;Norbert Heinrich;Gabriel Rojas-Ponce

  230
  Citations

• New Drugs for the Treatment of Tuberculosis: Needs, Challenges, Promise, and Prospects for the Future

  Christian Lienhardt;Mario Raviglione;Mel Spigelman;Richard Hafner

  227
  Citations